Literature DB >> 16435202

Mutation detection in four candidate genes (OXA1L, MRS2L, YME1L and MIPEP) for combined deficiencies in the oxidative phosphorylation system.

M J H Coenen1, J A M Smeitink, R Smeets, F J M Trijbels, L P van den Heuvel.   

Abstract

Mitochondria are the main energy-producing organelles of the cell. Five complexes embedded in the mitochondrial inner membrane, together constituting the oxidative phosphorylation (OXPHOS) system, comprise the final steps in cellular energy production. Many patients with a mitochondrial defect suffer from a so-called combined deficiency, meaning that the enzymatic activities of two or more complexes of the OXPHOS system are decreased. Numerous mutations have been described in nuclear genes that are involved in the functioning of a single complex of the OXPHOS system. However, little attention has been paid to patients with a deficiency of more than one complex of this particular system. In this study we have investigated four nuclear genes (OXA1L, MRS2L, YME1L and MIPEP) that might be involved in the pathology of combined enzymatic deficiencies of the OXPHOS system. Based on the results of yeast knockouts of these four proteins, we have sequenced the open reading frame of OXA1L in eight patients with an enzymatic deficiency of complexes I and IV. MRS2L, YME1L and MIPEP have been sequenced in three patients with a combined defect of complexes III and IV. No mutations were detected in these patients, showing that at least in these patients the OXPHOS system deficiency cannot be explained by a mutation in these four genes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16435202     DOI: 10.1007/s10545-005-4483-y

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  31 in total

Review 1.  Mitochondrial respiratory chain diseases and mutations in nuclear DNA: a promising start?

Authors:  C M Sue; E A Schon
Journal:  Brain Pathol       Date:  2000-07       Impact factor: 6.508

Review 2.  Mutations in mtDNA: are we scraping the bottom of the barrel?

Authors:  S DiMauro; A L Andreu
Journal:  Brain Pathol       Date:  2000-07       Impact factor: 6.508

3.  The human homologue of the yeast mitochondrial AAA metalloprotease Yme1p complements a yeast yme1 disruptant.

Authors:  Z H Shah; G A Hakkaart; B Arku; L de Jong; H van der Spek; L A Grivell; H T Jacobs
Journal:  FEBS Lett       Date:  2000-08-04       Impact factor: 4.124

4.  The bacterial magnesium transporter CorA can functionally substitute for its putative homologue Mrs2p in the yeast inner mitochondrial membrane.

Authors:  D M Bui; J Gregan; E Jarosch; A Ragnini; R J Schweyen
Journal:  J Biol Chem       Date:  1999-07-16       Impact factor: 5.157

5.  Sequence and structure of the human OXA1L gene and its upstream elements.

Authors:  A Rötig; B Parfait; L Heidet; G Dujardin; P Rustin; A Munnich
Journal:  Biochim Biophys Acta       Date:  1997-07-10

6.  Cloning, expression, and chromosomal assignment of the human mitochondrial intermediate peptidase gene (MIPEP).

Authors:  A Chew; E A Buck; S Peretz; G Sirugo; P Rinaldo; G Isaya
Journal:  Genomics       Date:  1997-03-15       Impact factor: 5.736

Review 7.  Microbial magnesium transport: unusual transporters searching for identity.

Authors:  R L Smith; M E Maguire
Journal:  Mol Microbiol       Date:  1998-04       Impact factor: 3.501

8.  Leigh syndrome: clinical features and biochemical and DNA abnormalities.

Authors:  S Rahman; R B Blok; H H Dahl; D M Danks; D M Kirby; C W Chow; J Christodoulou; D R Thorburn
Journal:  Ann Neurol       Date:  1996-03       Impact factor: 10.422

9.  Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics.

Authors:  Vamsi K Mootha; Pierre Lepage; Kathleen Miller; Jakob Bunkenborg; Michael Reich; Majbrit Hjerrild; Terrye Delmonte; Amelie Villeneuve; Robert Sladek; Fenghao Xu; Grant A Mitchell; Charles Morin; Matthias Mann; Thomas J Hudson; Brian Robinson; John D Rioux; Eric S Lander
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-14       Impact factor: 11.205

10.  Mammalian mitochondrial intermediate peptidase: structure/function analysis of a new homologue from Schizophyllum commune and relationship to thimet oligopeptidases.

Authors:  G Isaya; W R Sakati; R A Rollins; G P Shen; L C Hanson; R C Ullrich; C P Novotny
Journal:  Genomics       Date:  1995-08-10       Impact factor: 5.736

View more
  5 in total

Review 1.  Building the CuA site of cytochrome c oxidase: A complicated, redox-dependent process driven by a surprisingly large complement of accessory proteins.

Authors:  Kimberly A Jett; Scot C Leary
Journal:  J Biol Chem       Date:  2017-09-29       Impact factor: 5.157

2.  Homozygous YME1L1 mutation causes mitochondriopathy with optic atrophy and mitochondrial network fragmentation.

Authors:  Bianca Hartmann; Timothy Wai; Hao Hu; Thomas MacVicar; Luciana Musante; Björn Fischer-Zirnsak; Werner Stenzel; Ralph Gräf; Lambert van den Heuvel; Hans-Hilger Ropers; Thomas F Wienker; Christoph Hübner; Thomas Langer; Angela M Kaindl
Journal:  Elife       Date:  2016-08-06       Impact factor: 8.140

3.  How much does a disrupted mitochondrial network influence neuronal dysfunction?

Authors:  Zofia Ma Chrzanowska-Lightowlers; Robert N Lightowlers
Journal:  EMBO Mol Med       Date:  2019-01       Impact factor: 12.137

4.  A computational screen for regulators of oxidative phosphorylation implicates SLIRP in mitochondrial RNA homeostasis.

Authors:  Joshua M Baughman; Roland Nilsson; Vishal M Gohil; Daniel H Arlow; Zareen Gauhar; Vamsi K Mootha
Journal:  PLoS Genet       Date:  2009-08-14       Impact factor: 5.917

5.  OXA1L mutations cause mitochondrial encephalopathy and a combined oxidative phosphorylation defect.

Authors:  Kyle Thompson; Nicole Mai; Monika Oláhová; Filippo Scialó; Luke E Formosa; David A Stroud; Madeleine Garrett; Nichola Z Lax; Fiona M Robertson; Cristina Jou; Andres Nascimento; Carlos Ortez; Cecilia Jimenez-Mallebrera; Steven A Hardy; Langping He; Garry K Brown; Paula Marttinen; Robert McFarland; Alberto Sanz; Brendan J Battersby; Penelope E Bonnen; Michael T Ryan; Zofia Ma Chrzanowska-Lightowlers; Robert N Lightowlers; Robert W Taylor
Journal:  EMBO Mol Med       Date:  2018-11       Impact factor: 12.137

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.